I-Know

I-Know is a knowledge discovery IT -based tool designed to aid early stroke diagnosis, stroke treatment, drug development and identification of risk factors as targets in disease prevention for the benefit of European industry and citizens.

Acute stroke is a major socioeconomic burden in EU. The disabilities following the disease develop rapidly and prompt treatment of patients is imperative. Currently a drug dissolving the blood clot (rtPA - thrombolysis) is the only established treatment, but this is only implemented at highly specialised centres. There is consequently a strong geographical inequality in the availability of this treatment - nationally and internationally within EU.

At the same time there is an intense search by pharmaceutical industry and academic biomedical research to identify drugs that will stop the tissue damage progressing after acute stroke.

The knowledge discovery tool, I-Know will:

  • Provide instant, user-friendly ITbased diagnosis and therapeutic guidance, reducing the infrastructural, economic and educational barriers currently hindering advanced stroke treatment at less specialised units.
  • Use advanced data mining techniques to model disease progression based on large multinational databases providing state-of-theart diagnosis of every EU citizen irrespective of knowledge barriers.
  • Provide a platform for modeling beneficial or adverse effects recorded during clinical trials, allowing optimal use of preclinical data in subsequent individualized patient management.
  • Be designed to integrate data across descriptive levels to devise disease models that will bring scientific progress to stroke research.

For further information, please visit:
http://www.cfin.au.dk

Project co-ordinator:
Dept. Neuroradiology, Aarhus Sygehus, Aarhus University Hospital, (DK)

Partners:

  • Institut National de la Santé et de Recherche Medicale (FR)
  • Université Claude Bernard (FR)
  • Fundació Privada Institut d'Investigació Biomédica de Girona (SP)
  • University of Cambridge (UK)
  • Universitätsklinikum Hamburg-Eppendorf (DE)
  • Universitätsklinikum Freiburg für die Medizinische Fakultät der Albert-Ludwigs-Universität (DE)
  • Systematic Software Engineering A/S (DK)
  • Dimac A/S (DK)

Timetable: from 05/06 – to 04/09

Total cost: € 3.876.347

EC funding: € 3.092.810

Instrument: STREP

Project Identifier: IST-2004-027294

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...